Top

Gepubliceerd in:

01-02-2008 | Point of view

Remote monitoring in implantable defibrillator therapy

Auteurs: D. A. M. J. Theuns, L. J. Jordaens

Gepubliceerd in: Netherlands Heart Journal | Uitgave 2/2008

Abstract

The major device manufacturers have introduced systems for remote patient monitoring. These remote monitoring systems promise more efficient patient management, especially in today’s clinical setting with the growing number of defibrillator implantations. The aim of this article is to present the role of remote patient monitoring in implantable cardioverter-defibrillator follow-up, its potential benefits and its barriers to widespread diffusion. (Neth Heart J 2008;16:53-6.)

vorige artikel Contrast-enhanced versus non-enhanced three-dimensional echocardiography of left ventricular volumes

volgende artikel Hypothyroidism as the cause of atrioventricular block in an elderly patient

Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.

Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.

Theuns DA, Res JC, Jordaens LJ. Home monitoring in ICD therapy: future perspectives. Europace 2003;5:139-42.

Schwartzman D, Nallamothu N, Callans DJ, Preminger MW, Gottlieb CD, Marchlinski FE. Postoperative lead-related complications in patients with nonthoracotomy defibrillation lead systems. J Am Coll Cardiol 1995;26:776-86.

Rosenqvist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. Circulation 1998;98:663-70.

Senges-Becker JC, Klostermann M, Becker R, Bauer A, Siegler KE, Katus HA, et al. What is the “Optimal” follow-up schedule for ICD patients? Europace 2005;7:319-26.

Furman S, Escher DJW. Transtelephonic pacemaker monitoring. In: Schaldach M, Furman S, eds. Advances in pacemaker technology. Berlin: Springer, 1975:177-94.

Griffin JC, Schuenemeyer TD, Hess KR. Pacemaker follow-up: Its role in the detection and correction of pacemaker malfunction. Pacing Clin Electrophysiol 1986;9:387-91.

Vallario LE, Leman RB, Gillette PC. Pacemaker follow-up and adequacy of Medicare guidelines. Am Heart J 1988;116:11-5.

10.

Gessman LJ, Vielbig RE, Waspe LE, Moss L, Damm D, Sundeen F. Accuracy and clinical utility of transtelephonic pacemaker followup. Pacing Clin Electrophysiol 1995;18:1032-34.

11.

Anderson MH, Paul VE, Jones S, Ward DE, Camm AJ. Transtelephonic interrogation of the implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1992;15:1144-50.

12.

Mehta D, Nayak HM, Singson M, Chao S, Pe E, Camunas JL, et al. Late complications in patients with pectoral defibrillator implants with transvenous defibrillator lead systems: high incidence of insulation breakdown. Pacing Clin Electrophysiol 1998; 21:1893-900.

13.

Kron J, Herre J, Renfroe EG, Rizo-Patron C, Raitt M, Halperin B, et al. Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 2001;141:92-8.

14.

Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K, et al. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol 2003;41:73-80.

15.

Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 2005;28:926-32.

16.

Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007;115:2474-80.

17.

Becker R, Ruf-Richter J, Senges-Becker JC, Bauer A, Weretka S, Voss F, et al. Patient alert in implantable cardioverter defibrillators: toy or tool? J Am Coll Cardiol 2004;44:95-8.

18.

Vollmann D, Erdogan A, Himmrich E, Neuzner J, Becker D, Unterberg-Buchwald C, et al. Patient Alert to detect ICD lead failure: efficacy, limitations, and implications for future algorithms. Europace 2006;8:371-6.

19.

Joseph GK, Wilkoff BL, Dresing T, Burkhardt J, Khaykin Y. Remote interrogation and monitoring of implantable cardioverter defibrillators. J Interv Card Electrophysiol 2004;11:161-6.

20.

Schoenfeld MH, Compton SJ, Mead RH, Weiss DN, Sherfesee L, Englund J, et al. Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. Pacing Clin Electrophysiol 2004;27:757-63.

21.

Scholten MF, Thornton AS, Theuns DA, Res J, Jordaens LJ. Twiddler’s syndrome detected by home monitoring device. Pacing Clin Electrophysiol 2004;27:1151-2.

22.

Brugada P. What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up? Clin Res Cardiol 2006;95(Suppl 3):iii3-iii9.

23.

Varma N, Stambler B, Chun S. Detection of atrial fibrillation by implanted devices with wireless data transmission capability. Pacing Clin Electrophysiol 2005;28(Suppl 1):S133-6.

24.

Res JC, Theuns DA, Jordaens L. The role of remote monitoring in the reduction of inappropriate implantable cardioverter defibrillator therapies. Clin Res Cardiol 2006;95(Suppl 3):iii17-iii21.

25.

Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-40.

26.

Cleland JG. From left ventricular dysfunction to heart failure. Arch Mal Coeur Vaiss 1996;89:1397-402.

27.

Fantoni C, Raffa S, Regoli F, Giraldi F, La Rovere MT, Prentice J, et al. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol 2005;46:1875-82.

28.

Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin Electrophysiol 2007;30:S2-S12.

29.

Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 2005;45:1654-64.

30.

Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005;112:841-8.

Titel: Remote monitoring in implantable defibrillator therapy
Auteurs: D. A. M. J. Theuns
L. J. Jordaens
Publicatiedatum: 01-02-2008
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Netherlands Heart Journal / Uitgave 2/2008
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI: https://doi.org/10.1007/BF03086118

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2008

Alternatives for heart transplantation?

Left ventricular assist device: a functional comparison with heart transplantation

Ruptured sinus Valsalva aneurysm, a rare cause of heart failure

Contrast-enhanced versus non-enhanced three-dimensional echocardiography of left ventricular volumes

Hypothyroidism as the cause of atrioventricular block in an elderly patient